Cell Reports (Sep 2013)

Increased Mammalian Lifespan and a Segmental and Tissue-Specific Slowing of Aging after Genetic Reduction of mTOR Expression

  • J. Julie Wu,
  • Jie Liu,
  • Edmund B. Chen,
  • Jennifer J. Wang,
  • Liu Cao,
  • Nisha Narayan,
  • Marie M. Fergusson,
  • Ilsa I. Rovira,
  • Michele Allen,
  • Danielle A. Springer,
  • Cory U. Lago,
  • Shuling Zhang,
  • Wendy DuBois,
  • Theresa Ward,
  • Rafael deCabo,
  • Oksana Gavrilova,
  • Beverly Mock,
  • Toren Finkel

DOI
https://doi.org/10.1016/j.celrep.2013.07.030
Journal volume & issue
Vol. 4, no. 5
pp. 913 – 920

Abstract

Read online

We analyzed aging parameters using a mechanistic target of rapamycin (mTOR) hypomorphic mouse model. Mice with two hypomorphic (mTORΔ/Δ) alleles are viable but express mTOR at approximately 25% of wild-type levels. These animals demonstrate reduced mTORC1 and mTORC2 activity and exhibit an approximately 20% increase in median survival. While mTORΔ/Δ mice are smaller than wild-type mice, these animals do not demonstrate any alterations in normalized food intake, glucose homeostasis, or metabolic rate. Consistent with their increased lifespan, mTORΔ/Δ mice exhibited a reduction in a number of aging tissue biomarkers. Functional assessment suggested that, as mTORΔ/Δ mice age, they exhibit a marked functional preservation in many, but not all, organ systems. Thus, in a mammalian model, while reducing mTOR expression markedly increases overall lifespan, it affects the age-dependent decline in tissue and organ function in a segmental fashion.